- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01434758
Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture
Study Overview
Status
Conditions
Detailed Description
Tuberculosis (TB) is a major cause of morbidity and mortality among children in developing nations. Symptom-based diagnostic criteria are non-specific and culture confirmation is challenging, as sputum samples are often believed to be to too cumbersome to obtain from small children and specimens typically have low yield due to the paucibacillary nature of pediatric TB. Culture confirmation may be obtained in as few as 10% of cases of suspected pediatric TB. For these reasons, the true extent of the (drug-resistant) TB epidemic in children is unknown. Thus, either clinicians begin empiric treatment without diagnosis or no treatment is given at all. Current laboratory methods, if available at all in resource poor settings, employ smears from expectorated sputa or gastric aspirates which have low sensitivity in children. While more rapid diagnostic techniques such as PCR based tests have been developed, there is still poor sensitivity in children. Improving the diagnosis of pediatric TB must focus on better efforts, including more aggressive strategies to uncover disseminated disease.
Culture confirmation of disseminated disease can be obtained from blood, urine, cerebrospinal fluid (CSF), peritoneal and pleural fluid, or purulent material from lymph node aspirates, abscesses or otorrhea. Unfortunately, little is known about the overall yield from these various specimens in children. From pilot data collected among children at NHP, we know that it is feasible to collect and test various bodily fluid specimens for TB culture.
Although WHO guidelines encourage body fluid collection in order to make a diagnosis of TB in children, at present in NHP, blood and urine cultures are not obtained for mycobacterial culture. However, this study seeks to demonstrate that routine investigation of blood and urine will augment the yield of traditional sputum culture for children in whom disseminated disease is more likely. Improved culture confirmation will allow DST and a more accurate description of the drug-resistant TB epidemic for children in the region.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Hanoi, Vietnam
- National Hospital of Pediatrics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged 0-15, presenting at NHP;
- Unexplained fever for more than 2 weeks; and
Any form of TB suspected based on at least two of the following findings:
- unexplained cough for more than 2 weeks
- radiographic findings suggestive of tuberculosis.
- failure to thrive/weight loss
- enlarged non-tender lymph nodes or lymph node abscess, especially of the neck
- signs of meningitis with prodromal stage of at least one week
- HIV positive
- malnourished
- TB contact history
- Clinical judgment treating doctor.
- Relevant material (sputum or gastric aspirate, blood, and urine) available for microbiological diagnosis.
- Informed consent obtained from the patient's legal guardian(s).
Exclusion Criteria:
- Age >15 years
- Diagnosed or treated for TB in the past year, received drugs effective against TB in last 3 months.
- Clinical contra-indications to collect the required study specimens
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Children
Children age 0-15 years presenting to NHP thought to have TB infection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic yield of TB culture
Time Frame: At baseline - day 1 of study
|
Number of positive TB cultures versus number of positive TB direct smears for expectorate and/or gastric aspirate.
|
At baseline - day 1 of study
|
|
Diagnostic yield of TB culture
Time Frame: At baseline - day 1 of study
|
Number of positive TB cultures versus number of positive MODS cultures for expectorate and/or gastric aspirate.
|
At baseline - day 1 of study
|
|
Diagnostic yield of urine versus expectorate or gastric aspirate for TB culture
Time Frame: At baseline - day 1 of study
|
Number of positive TB cultures in urine versus expectorate and/or gastric aspirate.
|
At baseline - day 1 of study
|
Collaborators and Investigators
Collaborators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09TB
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tuberculosis Infection
-
Queen Mary University of LondonEnrolling by invitationLatent Tuberculosis Infection | Tuberculosis Infection, LatentUnited Kingdom
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Active, not recruiting
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR)RecruitingTuberculosis Infection, LatentCanada, Vietnam, Brazil, Benin, Indonesia
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Shenzhen Third People's Hospital; Wuhan Institute for Tuberculosis ControlCompletedLatent Tuberculosis InfectionChina
-
Pontificia Universidad Catolica de ChileRecruitingAdolescent | Tuberculosis | Children | Tuberculosis Infection | Household Contacts | Tuberculosis Infection, LatentChile
-
National Taiwan University HospitalUnknownLatent Tuberculosis InfectionTaiwan
-
Samsung Medical CenterCompletedLatent Tuberculosis InfectionKorea, Republic of
-
Aarhus University HospitalBandim Health ProjectNot yet recruitingPregnancy | Maternal Health | Tuberculosis (TB) | Tuberculosis Diagnosis | Tuberculosis Infection, LatentGuinea-Bissau
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Latent Tuberculosis Infection (LTBI)United States
-
Serum Institute of India Pvt. Ltd.Vakzine Projekt Management GmbHCompletedMycobacterium Tuberculosis InfectionGabon, Kenya, South Africa, Tanzania, Uganda